This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
Troyen A. Brennan, MD, JD, is the leading medicolegal scholar at Harvard Medical School and School of Public Health. Donald M. Berwick, MD, president and chief executive officer of the Institute for Healthcare Improvement, probably is the leading figure in the movement for quality improvement (QI) in health care. Both maintain active clinical practices. From two such collaborators, one has high hopes for a book on emerging challenges in health regulation.
To a very large extent, this book fulfills the promise. It is intelligent and extraordinarily well informed. The style is variable, perhaps reflecting the dual authorship: sometimes the reading is engaging; at other times the parade of statutes, regulations, and holdings becomes extremely dry. One misses more sustained argument against opposing views; the approach here is unlikely to convince a reader who did not start out sympathetic to it. And inevitably in a work dealing with recent developments, some
Gold JA. New Rules: Regulation, Markets, and the Quality of American Health Care. JAMA. 1996;276(2):165. doi:10.1001/jama.1996.03540020087039